Skip to main content
. 2016 May 10;128(2):185–194. doi: 10.1182/blood-2016-02-699520

Figure 2.

Figure 2

Overview of panobinostat response duration. (A) This shows the Kaplan-Meier progression-free survival (PFS) curve for all patients on the trial (solid line) contrasted with responders (dashed line) (N = 40 patients). (B) This plot shows treatment duration (red bar) and PFS (blue bar) or each patient. +, ongoing response at last follow-up.